Carbidopa and Levodopa Extended Release Capsules in Patients with and without Troublesome and Non-Troublesome Dyskinesia

BACKGROUND: Carbidopa (CD) and levodopa (LD) extended release (CD-LD ER) capsules are designed to combine both immediate and extended release pharmacokinetics. In the phase 3, randomized, double-blind, ADVANCE-PD trial, patients randomized to CD-LD ER experienced a 1.17-hour greater reduction in OFF...

Descripción completa

Detalles Bibliográficos
Autores principales: Hauser, Robert A., Zeitlin, Leonid, Fisher, Stanley, D’Souza, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458518/
https://www.ncbi.nlm.nih.gov/pubmed/32568108
http://dx.doi.org/10.3233/JPD-202010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458518/
https://www.ncbi.nlm.nih.gov/pubmed/32568108
http://dx.doi.org/10.3233/JPD-202010

Ejemplares similares